Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

EPO peptides and anti-EPO antibodies from Behringwerke

Feb. 3, 1998

Somatostatin receptor ligands synthesized by Novo Nordisk

Feb. 2, 1998

Schering-Plough to copromote Novo Nordisk's Prandin

Jan. 30, 1998

Oxytocin antagonist licensed by Tokyo Tanabe enters clinic

Jan. 30, 1998

Roche patents vitamin D analogues for osteoporosis

Jan. 30, 1998

Comparative trial of intracavernous alprostadil and MUSE for ED

Jan. 29, 1998

BioMarin's lead enzyme replacement therapy enters clinical trials

Jan. 28, 1998

Common variant of CETP gene correlated with atherosclerosis progression, response to pravastatin

Jan. 27, 1998

Wyeth-Ayerst licenses PEPCK-modulating compounds

Jan. 27, 1998

Squalene synthase inhibitors patented by Pfizer

Jan. 26, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...